← back to search

Octavio Martínez

University of Miami · US
Area of research
Molecular Medicine · Epidemiology
Research interest
Research interests include Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Bacterial Identification and Susceptibility Testing, and Mycobacterium research and diagnosis.
h-index
23
citations
1,627
works
156
NIH funding
primary concept
email

Recent publications

Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio study
Antimicrobial Agents and Chemotherapy 2025cited by 6position: middledoi
Impact of In-house <i>Candida auris</i> Polymerase Chain Reaction Screening on Admission on the Incidence Rates of Surveillance and Blood Cultures With <i>C. auris</i> and Associated Cost Savings
Open Forum Infectious Diseases 2023cited by 15position: middledoi
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
PLoS ONE 2022cited by 22position: middledoi
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa
European Journal of Clinical Microbiology & Infectious Diseases 2021cited by 90position: middledoi
Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL: A retrospective cohort study
American Journal of Infection Control 2021cited by 13position: middledoi
Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant<i>Pseudomonas aeruginosa</i>Using the ERACE-PA Global Surveillance Program
Open Forum Infectious Diseases 2021cited by 11position: middledoi
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization
Antimicrobial Agents and Chemotherapy 2021cited by 10position: middledoi
Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts
F1000Research 2020cited by 56position: middledoi
False‐positive reverse transcriptase polymerase chain reaction screening for SARS‐CoV‐2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications
Head & Neck 2020cited by 44position: middledoi
KPC-3–Producing<i>Serratia marcescens</i>Outbreak between Acute and Long-Term Care Facilities, Florida, USA
Emerging infectious diseases 2020cited by 18position: middledoi
Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient
Mycopathologia 2020cited by 11position: middledoi
Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts
F1000Research 2019cited by 46position: middledoi
Next Generation Sequencing of Microbial Cell-Free DNA for Rapid Noninvasive Diagnosis of Infectious Diseases in Immunocompromised Hosts
Biology of Blood and Marrow Transplantation 2019cited by 12position: middledoi
Clinical Impact of BioFire Film Array in Pediatric Sepsis
Journal of Pediatric Infectious Diseases 2019cited by 2position: middledoi
Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome Sequencing
Clinical Infectious Diseases 2018cited by 41position: middledoi
<i>In Vitro</i> Discordance with <i>In Vivo</i> Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in a Murine Lung Infection Model
Antimicrobial Agents and Chemotherapy 2017cited by 42position: middledoi
Application of “Precision Medicine” Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient
Clinical Infectious Diseases 2017cited by 17position: middledoi
“Double carbapenem” and oral fosfomycin for the treatment of complicated urinary tract infections caused by <i>bla</i><sub>NDM</sub>‐harboring Enterobacteriaceae in kidney transplantation
Transplant Infectious Disease 2017cited by 16position: middledoi
High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study
AIDS Research and Human Retroviruses 2016cited by 51position: middledoi
Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study
PLoS ONE 2016cited by 39position: middledoi
Solid organ transplant antibiograms: an opportunity for antimicrobial stewardship
Diagnostic Microbiology and Infectious Disease 2016cited by 32position: middledoi
Fungal Infections of the Spine
Spine 2015cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

José F. Camargo · University of Miami9 papers (2016–2020)Lilian M. Abbo · University of Miami9 papers (2016–2023)Rossana Rosa · Horizon Health Network5 papers (2016–2023)David P. Nicolau · Brown University5 papers (2017–2021)Krishna V. Komanduri · UCSF Helen Diller Family Comprehensive Cancer Center4 papers (2019–2020)Clara E. Prado · University of Miami4 papers (2019–2020)Adriana Jiménez · University of Miami4 papers (2018–2023)Michele I. Morris · University of Miami4 papers (2019–2020)Robert A. Bonomo · Louis Stokes Cleveland VA Medical Center4 papers (2017–2022)Carey‐Ann D. Burnham · NewYork–Presbyterian Hospital3 papers (2021–2021)Rafael Cantón · Madrid Institute for Advanced Studies3 papers (2021–2021)Shweta Anjan · University of Miami3 papers (2019–2020)Sudeb C. Dalai · University of San Francisco3 papers (2019–2020)Marco Falcone · University of Turin3 papers (2021–2021) · 3 papers (2021–2021)Lori Bourassa · Seattle University3 papers (2021–2021)Adrian Brink · Wellcome Centre for Infectious Diseases Research in Africa3 papers (2021–2021) · 3 papers (2021–2021)Abrar K. Thabit · University of Houston3 papers (2021–2021)Armando Pérez-Cardona · Jackson Memorial Hospital3 papers (2017–2022)